Red Blood Cell Distributions (RDW, RDW-CW) and Lymphocyte Monocyte Ratios (LMR) for the Malignant Thyroid Nodules
NCT ID: NCT06283368
Last Updated: 2024-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
172 participants
OBSERVATIONAL
2016-01-31
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Tumor-related inflammation is activated as a result of bone marrow and inflammation induced by malignancies. Insufficiently controlled or uncontrolled inflammatory activity may be responsible for malignant transformation. Lymphocyte monocyte ratio and red blood cell distribution are parameters (RDW, RDW-CW) previously studied in terms of cancers.
Our aim in this study is to reveal the RDW, RDW-CW, and LMR calculated from complete blood count parameters in the preoperative period, as an indicator of malignant inflammatory response, in a non-invasive and inexpensive way before surgery or biopsy is performed to distinguish nodular goiter and thyroid malignancy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The No-Tie Technique Using the Harmonic Scalpel in Total Thyroidectomy With Central Neck Dissection: A Prospective Randomized Study
NCT00506103
The Effect of Thyroid Lobe Volume on the Common Carotid Artery Blood Flow
NCT06797388
Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer
NCT06793579
Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients
NCT06468696
Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System
NCT01565486
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Benign Thyroid Pathologies
Nodular Goiter Graves Diseases Tocsic Thyroid Nodular Disease
Thyroidectomy, Bilaterally Total
Thyroidectomy, Bilaterally Total
Thyroidectomy, Unilaterally Total
Thyroidectomy, Unilaterally Total
Thyroidectomy, Complementary
Thyroidectomy, Complementary
Thyroidectomy, Near Total
Thyroidectomy, Near Total
Thyroid Cancer Cases
Papillary Thyroid Carcinoma Medullary Thyroid Carcinoma Hurthle Cell Carcinoma Anaplastic Thyroid Carcinoma
Thyroidectomy, Bilaterally Total
Thyroidectomy, Bilaterally Total
Thyroidectomy, Unilaterally Total
Thyroidectomy, Unilaterally Total
Thyroidectomy, Complementary
Thyroidectomy, Complementary
Thyroidectomy, Near Total
Thyroidectomy, Near Total
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thyroidectomy, Bilaterally Total
Thyroidectomy, Bilaterally Total
Thyroidectomy, Unilaterally Total
Thyroidectomy, Unilaterally Total
Thyroidectomy, Complementary
Thyroidectomy, Complementary
Thyroidectomy, Near Total
Thyroidectomy, Near Total
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Thyroidectomy cases
Exclusion Criteria
* Patients with other system malignancies
* Patients with missing data
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Buğra Bozan
Professor, Associate
References
Explore related publications, articles, or registry entries linked to this study.
Bozan MB, Yazar FM, Kale IT, Yuzbasioglu MF, Boran OF, Azak Bozan A. Delta Neutrophil Index and Neutrophil-to-Lymphocyte Ratio in the Differentiation of Thyroid Malignancy and Nodular Goiter. World J Surg. 2021 Feb;45(2):507-514. doi: 10.1007/s00268-020-05822-6. Epub 2020 Oct 16.
Lee F, Yang PS, Chien MN, Lee JJ, Leung CH, Cheng SP. An Increased Neutrophil-to-Lymphocyte Ratio Predicts Incomplete Response to Therapy in Differentiated Thyroid Cancer. Int J Med Sci. 2018 Nov 23;15(14):1757-1763. doi: 10.7150/ijms.28498. eCollection 2018.
Wen W, Wu P, Li J, Wang H, Sun J, Chen H. Predictive values of the selected inflammatory index in elderly patients with papillary thyroid cancer. J Transl Med. 2018 Sep 21;16(1):261. doi: 10.1186/s12967-018-1636-y.
Yaylaci S, Tosun O, Sahin O, Genc AB, Aydin E, Demiral G, Karahalil F, Olt S, Ergenc H, Varim C. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer. Asian Pac J Cancer Prev. 2016;17(4):2321-3. doi: 10.7314/apjcp.2016.17.4.2321.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/11-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.